Cargando…
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
Antibodies are a potential therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the risk of the virus evolving to escape them remains unclear. Here we map how all mutations to the receptor binding domain (RBD) of SARS-CoV-2 affect binding by the antibodies in the REGN-COV2 c...
Autores principales: | Starr, Tyler N., Greaney, Allison J., Addetia, Amin, Hannon, William W., Choudhary, Manish C., Dingens, Adam S., Li, Jonathan Z., Bloom, Jesse D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963219/ https://www.ncbi.nlm.nih.gov/pubmed/33495308 http://dx.doi.org/10.1126/science.abf9302 |
Ejemplares similares
-
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
por: Starr, Tyler N., et al.
Publicado: (2020) -
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
por: Starr, Tyler N., et al.
Publicado: (2021) -
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
por: Starr, Tyler N., et al.
Publicado: (2021) -
An antibody-escape calculator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J., et al.
Publicado: (2021) -
An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J, et al.
Publicado: (2022)